Skip to main content
SpringerLink
Log in

What Factors of My Crohn’s Disease Put Me at Higher Risk of Complications? Identifying Crohn’s Patients with Severe Disease

  • Chapter
Inflammatory Bowel Disease

  • 1373 Accesses

Abstract

Although not all patients with Crohn’s disease will develop irreversible bowel damage leading to complications such as strictures and fistulas, there is a large number that will. Identifying those people at higher risk of developing these complications is not always easy, but there are certain risk factors that have been associated with disease that is more likely to progress over time.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Cosnes J, Cattan S, Blain A, Beaugerie L, Carbonnel F, Parc R, et al. Long-term evolution of disease behavior of Crohn’s disease. Inflamm Bowel Dis. 2002;8:244–50.

    Article  PubMed  Google Scholar 

  2. Louis E, Colard A, Oger AF, Degroote E, El Yafi F, Belaiche J. Behaviour of Crohn’s disease according to the Vienna classification: changing pattern over the course of the disease. Gut. 2001;49:777–82.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  3. Lakatos PL, Czegledi Z, Szamosi T, Banai J, David G, Zsigmond F, et al. Perianal disease, small bowel disease, smoking, prior steroid or early azathioprine/biologic therapy are predictors of disease behavior change in patients with Crohn’s disease. World J Gastroenterol. 2009;15:3504–10.

    Article  PubMed Central  PubMed  Google Scholar 

  4. Lakatos PL, Golovics PA, David G, Pandur T, Erdelyi Z, Horvath A, et al. Has there been a change in the natural history of Crohn’s disease? Surgical rates and medical management in a population-based inception cohort from Western Hungary between 1977–2009. Am J Gastroenterol. 2012;107:579–88.

    Article  CAS  PubMed  Google Scholar 

  5. Thia KT, Sandborn WJ, Harmsen WS, Zinsmeister AR, Loftus EV. Risk factors associated with progression to intestinal complications of Crohn’s disease in a population-based cohort. Gastroenterology. 2010;139:1147–55.

    Article  PubMed Central  PubMed  Google Scholar 

  6. Smith BR, Arnott ID, Drummond HE, Nimmo ER, Satsangi J. Disease location, anti-Saccharomyces cerevisiae antibody, and NOD2/CARD15 genotype influence the progression of disease behavior in Crohn’s disease. Inflamm Bowel Dis. 2004;10:521–8.

    Article  PubMed  Google Scholar 

  7. Aldhous MC, Drummond HE, Anderson N, Smith LA, Arnott ID, Satsangi J. Does cigarette smoking influence the phenotype of Crohn’s disease? Analysis using the Montreal classification. Am J Gastroenterol. 2007;102:577–88.

    Article  PubMed  Google Scholar 

  8. Louis E, Michel V, Hugot JP, Reenaers C, Fontaine F, Delforge M, et al. Early development of stricturing or penetrating pattern in Crohn’s disease is influenced by disease location, number of flares, and smoking but not by NOD2/CARD15 genotype. Gut. 2003;52:552–7.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  9. Beaugerie L, Seksik P, Nion-Larmurier I, Gendre JP, Cosnes J. Predictors of Crohn’s disease. Gastroenterology. 2006;130:650–6.

    Article  PubMed  Google Scholar 

  10. Seksik P, Loftus EV, Beaugerie L, Harmsen WS, Zinsmeister AR, Cosnes J, et al. Validation of predictors of 5-year disabling CD in a population-based cohort from Olmsted County, Minnesota, 183–1996. Gastroenterology. 2007;132:A17.

    Article  Google Scholar 

  11. Lovasz BD, Lakatos L, Horvath A, Szita I, Pandur T, Mandel M, et al. Evolution of disease phenotype in adult and pediatric onset Crohn’s disease in a population-based cohort. World J Gastroenterol. 2013;19:2217–26.

    Article  PubMed Central  PubMed  Google Scholar 

  12. Loly C, Belaiche J, Louis E. Predictors of severe Crohn’s disease. Scand J Gastroenterol. 2008;43:948–54.

    Article  CAS  PubMed  Google Scholar 

  13. Tang LY, Rawsthorne P, Bernstein CN. Are perineal and luminal fistulas associated in Crohn’s disease? A population-based study. Clin Gastroenterol Hepatol. 2006;4:1130–4.

    Article  PubMed  Google Scholar 

  14. Veloso FT, Ferreira JT, Barros L, Almeida S. Clinical outcome of Crohn’s disease, analysis according to the Vienna classification and clinical activity. Inflamm Bowel Dis. 2001;7:306–13.

    Article  CAS  PubMed  Google Scholar 

  15. Eglinton TW, Gearry RB. Clinical factors predicting disease course in Crohn’s disease. Expert Rev Clin Immunol. 2010;6:41–5.

    Article  PubMed  Google Scholar 

  16. Picco MF, Bayless TM. Tobacco consumption and disease duration are associated with fistulizing and stricturing behaviors in the first 8 years of Crohn’s disease. Am J Gastroenterol. 2003;98:363–8.

    Article  PubMed  Google Scholar 

  17. Allez M, Lemann M, Bonnet J, Cattan P, Jian R, Modigliani R. Long term outcome of patients with active Crohn’s disease exhibiting extensive and deep ulcerations at colonoscopy. Am J Gastroenterol. 2002;97:947–53.

    PubMed  Google Scholar 

  18. Targan SR, Landers CJ, Yang H, Lodes MJ, Cong Y, Papadakis KA, et al. Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn’s disease. Gastroenterology. 2005;128:2020–8.

    Article  CAS  PubMed  Google Scholar 

  19. Arnott ID, Landers CJ, Nimmo EJ, Drummond HE, Smith BK, Targan SR, et al. Sero-reactivity to microbial components in Crohn’s disease is associated with disease severity and progression, but not NOD2/CARD15 genotype. Am J Gastroenterol. 2004;99:2376–84.

    Article  PubMed  Google Scholar 

  20. Vasiliauskas EA, Kam LY, Karp LC, Gaiennie J, Yang H, Targan SR. Marker antibody expression stratifies Crohn’s disease into immunologically homogeneous subgroups with distinct clinical characteristics. Gut. 2000;47:487–96.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  21. Dubinsky M. What is the role of serological markers in IBD? Pediatric and adult data. Dig Dis. 2009;27:259–68.

    Article  PubMed  Google Scholar 

  22. Abreu MT, Taylor KD, Lin YC, Hang T, Gaiennie J, Landers JC, et al. Mutations in NOD2 are associated with fibrostenotic disease in patients with Crohn’s disease. Gastroenterology. 2002;123:679–88.

    Article  CAS  PubMed  Google Scholar 

  23. Alvarez-Lobos M, Arostegui JI, Sans M, Tassies D, Plaza S, Delgado S, et al. Crohn’s disease patients carrying Nod2/CARD15 gene variants have an increased and early need for first surgery due to stricturing disease and higher rates of surgical recurrence. Ann Surg. 2005;242:693–700.

    Article  PubMed Central  PubMed  Google Scholar 

  24. Renda MC, Cottone M. Prevalence of CARD15/NOD2 mutations in the Sicilian population. Am J Gastroenterol. 2008;103:248–9.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Gastroenterology, Department of Medicine, The Ottawa Hospital, General Campus, 501 Smyth Road, Block W1201–W1224, 191, Ottawa, ON, Canada, K14 8L6

    Liliana Oliveira M.D., F.R.C.P.(c)

Authors
  1. Liliana Oliveira M.D., F.R.C.P.(c)
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Liliana Oliveira M.D., F.R.C.P.(c) .

Editor information

Editors and Affiliations

  1. Division of Gastroenterology and Hepatology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA

    Daniel J. Stein

  2. Chief, Division Gastroenterology and Hepatology Digestive Disease Center, Medical College of Wisconsin, Milwaukee, Wisconsin, USA

    Reza Shaker

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Oliveira, L. (2015). What Factors of My Crohn’s Disease Put Me at Higher Risk of Complications? Identifying Crohn’s Patients with Severe Disease. In: Stein, D., Shaker, R. (eds) Inflammatory Bowel Disease. Springer, Cham. https://doi.org/10.1007/978-3-319-14072-8_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-14072-8_8

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-14071-1

  • Online ISBN: 978-3-319-14072-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation